Abbott

Manager Entity Controlling

Luxembourg, Luxembourg, Luxembourg

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Financial Services, AccountingIndustries

Requirements

Candidates should possess a Bachelor’s or Master’s degree in Accounting, Business Economics, or a related field, along with a minimum of 7 years of experience in financial leadership roles within international environments. They should demonstrate deep knowledge of financial principles, accounting regulations (US GAAP & Lux GAAP), and internal control frameworks, and experience bridging Finance & IT systems, driving digital transformation within finance operations. Fluency in English is required, with proficiency in French or German being a plus.

Responsibilities

As a Manager Entity Controlling, the individual will ensure accurate and timely financial transactions and reporting for Abbott Luxemburg Finance SARL and other assigned entities, maintain accounting records in line with Abbott’s policies, collaborate with management teams to streamline processes and optimize financial reporting, lead financial integrity efforts by ensuring regulatory and compliance adherence, develop and enhance financial processes to drive operational efficiency, act as the primary contact for internal and external audits, manage tax compliance (direct and indirect), oversee tax audits, drive financial reporting excellence, balance sheet reconciliations, and risk calculations, and cultivate an environment of innovation and continuous improvement, challenging the status quo to advance financial systems and strategies.

Skills

US GAAP
Lux GAAP
Financial Reporting
Accounting Regulations
Internal Controls
Financial Leadership
Tax Compliance
Direct Tax
Indirect Tax
Audit
Financial Systems
Digital Transformation
Process Optimization
Risk Calculations
Balance Sheet Reconciliation

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Key Metrics

Lake Bluff, IllinoisHeadquarters
1888Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.
Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.
Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.
Abbott's microfluidic devices streamline diagnostic processes efficiently.
Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.
Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.
Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI